CA3246924A1 - Dendritic molecules, their preparation process and their uses - Google Patents
Dendritic molecules, their preparation process and their usesInfo
- Publication number
- CA3246924A1 CA3246924A1 CA3246924A CA3246924A CA3246924A1 CA 3246924 A1 CA3246924 A1 CA 3246924A1 CA 3246924 A CA3246924 A CA 3246924A CA 3246924 A CA3246924 A CA 3246924A CA 3246924 A1 CA3246924 A1 CA 3246924A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compound
- group
- och3
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/003—Dendrimers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22305547.6A EP4261244A1 (en) | 2022-04-14 | 2022-04-14 | Dendritic molecules, process for their preparation and uses thereof |
| EP22305547.6 | 2022-04-14 | ||
| PCT/EP2023/059630 WO2023198813A1 (en) | 2022-04-14 | 2023-04-13 | Dendritic molecules, process for their preparation and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3246924A1 true CA3246924A1 (en) | 2023-10-19 |
Family
ID=81851615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3246924A Pending CA3246924A1 (en) | 2022-04-14 | 2023-04-13 | Dendritic molecules, their preparation process and their uses |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250376485A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4261244A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025512340A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119013334A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023252505A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3246924A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK4508118T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES3056645T3 (cg-RX-API-DMAC10.html) |
| FI (1) | FI4508118T3 (cg-RX-API-DMAC10.html) |
| PL (1) | PL4508118T3 (cg-RX-API-DMAC10.html) |
| PT (1) | PT4508118T (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023198813A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119841958B (zh) * | 2024-07-31 | 2025-10-28 | 中国农业大学 | 一种广谱识别喹诺酮类药物的纳米抗体及其制备方法与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3125949B1 (en) * | 2014-04-01 | 2023-11-08 | Centre National De La Recherche Scientifique | Dendronized metallic oxide nanoparticles, a process for preparing the same and their uses |
-
2022
- 2022-04-14 EP EP22305547.6A patent/EP4261244A1/en not_active Withdrawn
-
2023
- 2023-04-13 PT PT237202460T patent/PT4508118T/pt unknown
- 2023-04-13 FI FIEP23720246.0T patent/FI4508118T3/fi active
- 2023-04-13 US US18/856,603 patent/US20250376485A1/en active Pending
- 2023-04-13 AU AU2023252505A patent/AU2023252505A1/en active Pending
- 2023-04-13 ES ES23720246T patent/ES3056645T3/es active Active
- 2023-04-13 DK DK23720246.0T patent/DK4508118T3/da active
- 2023-04-13 WO PCT/EP2023/059630 patent/WO2023198813A1/en not_active Ceased
- 2023-04-13 CA CA3246924A patent/CA3246924A1/en active Pending
- 2023-04-13 PL PL23720246.0T patent/PL4508118T3/pl unknown
- 2023-04-13 EP EP23720246.0A patent/EP4508118B1/en active Active
- 2023-04-13 JP JP2024559719A patent/JP2025512340A/ja active Pending
- 2023-04-13 CN CN202380033952.0A patent/CN119013334A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4508118A1 (en) | 2025-02-19 |
| EP4508118B1 (en) | 2025-11-26 |
| EP4261244A1 (en) | 2023-10-18 |
| JP2025512340A (ja) | 2025-04-17 |
| US20250376485A1 (en) | 2025-12-11 |
| DK4508118T3 (da) | 2026-02-23 |
| FI4508118T3 (fi) | 2026-02-10 |
| PL4508118T3 (pl) | 2026-04-07 |
| WO2023198813A1 (en) | 2023-10-19 |
| PT4508118T (pt) | 2026-02-26 |
| CN119013334A (zh) | 2024-11-22 |
| ES3056645T3 (en) | 2026-02-23 |
| AU2023252505A1 (en) | 2024-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5932338B2 (ja) | ジピロメテン−ホウ素親水性蛍光性化合物 | |
| EP4508118B1 (en) | Dendritic molecules, process for their preparation and uses thereof | |
| Cram et al. | Host-guest complexation. 29. Expanded hemispherands | |
| CN112592360A (zh) | 一类两亲性氮杂氟硼二吡咯近红外染料及其制备方法 | |
| CN103055328B (zh) | 一种可降解树枝状大分子磁共振造影剂及其制备方法 | |
| KR101354123B1 (ko) | 관능화된 나노입자, 그의 제조 및 용도 | |
| CA3247792A1 (en) | Compositions of dispersed systems for biomedical applications, their preparation process and their uses | |
| CN103709410B (zh) | 酸敏感两亲性嵌段共聚物及其自组织胶束、用途 | |
| Gomar-Nadal et al. | Synthesis of optically active amphiphilic tetrathiafulvalene derivatives | |
| CN102093403B (zh) | 含偶氮苯基团的复合脂质及其中间体,制备方法与用途 | |
| Gataulina et al. | Synthesis and complexing properties of p-toluensulfonylamido and phosphorylamido derivatives of second-generation hyperbranched polyester | |
| US9133114B2 (en) | Dendrimers and methods of preparing same through proportionate branching | |
| Jiang et al. | The design and synthesis of highly branched and spherically symmetric fluorinated macrocyclic chelators | |
| Porwanski et al. | Bis-β-cyclodextrinyl-and bis-cellobiosyl-diazacrowns: synthesis and molecular complexation behaviors toward Busulfan anticancer agent and two basic aminoacids | |
| Du et al. | Synthesis of NO–NSAID dendritic prodrugs via Passerini reaction: new approach to the design of dendrimer-drug conjugates | |
| Wan et al. | Synthesis and characterization of DOTA-mono-adamantan-1-ylamide | |
| Hu et al. | Synthesis of Fan‐Shaped C3 Molecule with Three Glycyrrhetinic Acid Units and Self‐Assembly Properties | |
| CN103588752A (zh) | 一种甲基丙烯酸原酸酯类新单体及其两亲性嵌段共聚物制备方法和应用 | |
| CN109134282B (zh) | 一种树状多缩乙二醇衍生物及其制备方法和应用 | |
| WO2025022130A1 (en) | Dendrimers comprising fluorescent dyes | |
| Pasteur | A Liquid-Crystalline [2] Catenane and Its Copper (I) Complex | |
| CN119504854A (zh) | 一种近红外二区荧光标记的磷脂分子的制备方法及其脂质纳米载体的制备方法 | |
| EP1240239A1 (fr) | Polyphenoxydendrimeres colores, nouveaux supports solubles, leur procede de preparation et leur utilisation en synthese organique | |
| CN114702534A (zh) | 次氯酸触发激活型近红外荧光探针及其制备方法和应用 | |
| WO2018125524A1 (en) | Dendritic ligands for controlling self assembly and surface polarity of nanoparticles, and hybrid nanoparticles produced therefrom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT Effective date: 20240926 |
|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET Effective date: 20241010 |
|
| A15 | Pct application entered into the national or regional phase |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241010 |
|
| P18 | Priority claim added or amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241010 |
|
| P22 | Classification modified |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED Effective date: 20241010 |
|
| R00 | Party data change recorded |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R00-R101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: SMALL ENTITY DECLARATION DETERMINED COMPLIANT Effective date: 20241010 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20241010 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20241118 |
|
| R00 | Party data change recorded |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R00-R113 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF ADDRESS OR METHOD OF CORRESPONDENCE REQUEST RECEIVED Effective date: 20250317 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W200 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST OR RESPONSE SUBMITTED ONLINE Effective date: 20250327 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - SMALL Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250402 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250402 |
|
| R18 | Changes to party contact information recorded |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R18-R143 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF ADDRESS REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250811 Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R18-R114 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF METHOD OF CORRESPONDENCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250811 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250811 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - SMALL Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260331 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260331 |